The First Affiliated Hospital Of University Of Science And Technology Of China
Clinical trials sponsored by The First Affiliated Hospital Of University Of Science And Technology Of China, explained in plain language.
-
New combo therapy aims to boost stroke recovery and reduce disability
Disease control Not yet recruitingThis study tests whether adding baricitinib, an anti-inflammatory drug, to standard emergency stroke treatment helps patients recover better after a major stroke. About 750 adults with a large-vessel blockage stroke will receive baricitinib or placebo alongside the usual procedur…
Phase: PHASE2, PHASE3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated May 26, 2026 11:57 UTC
-
New combo therapy aims to wipe out aggressive rectal cancer before surgery
Disease control Not yet recruitingThis study tests a combination of chemotherapy, radiation, and immunotherapy (PD-1 therapy) given before surgery for people with locally advanced rectal cancer that has a high chance of coming back. The goal is to see if this approach can completely eliminate the tumor before sur…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated May 26, 2026 11:51 UTC
-
Could a simple shot help stroke patients when surgery isn't an option?
Disease control Not yet recruitingThis study tests whether the clot-busting drug tenecteplase can help people who have had a stroke caused by a large blocked artery in the brain, but cannot have a procedure to remove the clot. About 794 adults who had a stroke 4.5 to 24 hours earlier will either get tenecteplase …
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated May 22, 2026 13:50 UTC